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Several GTP binding proteins, including EF-Tu, Ypt1,
rab-5, and FtsY, and adenylosuccinate synthetase have
been reported to bind xanthine nucleotides when the
conserved aspartate residue in the NKXD motif was
changed to asparagine. However, the corresponding sin-
gle Goa mutant protein (D273N) did not bind either xan-
thine nucleotides or guanine nucleotides. Interestingly,
the introduction of a second mutation to generate the
Goa subunit D273N/Q205L switched nucleotide binding
specificity to xanthine nucleotide. The double mutant
protein GoaD273N/Q205L (GoaX) bound xanthine
triphosphate, but not guanine triphosphate. Recombi-
nant GoaX (GoaD273N/Q205L) formed heterotrimers
with bg complexes only in the presence of xanthine
diphosphate (XDP),1 and the binding to bg was inhibited
by xanthine triphosphate (XTP). Furthermore, as a re-
sult of binding to XTP, the GoaX protein underwent a
conformational change similar to that of the activated
wild-type Goa. In transfected COS-7 cells, we demon-
strate that the interaction between GoaX and bg oc-
curred only when cell membranes were permeabilized
to allow the uptake of xanthine diphosphate. This is the
first example of a switch in nucleotide binding specific-
ity from guanine to xanthine nucleotides in a heterotri-
meric G protein a subunit.
G proteins transduce receptor-generated signals across the
plasma membranes of eukaryotic cells. They are heterotrimeric
complexes composed of a, b, and g subunits. Each of the sub-
units belongs to a multigene protein family, containing at least
18 distinct a, 5 b, and 11 g subunits. Hundreds of seven-
transmembrane receptors activated by a great variety of hor-
mones, neuromediators, and growth factors are coupled to G
proteins. Receptor-induced activation of a G protein leads to
exchange of GDP for GTP bound to the a subunit. The GTP-
bound a subunit is released from the abg trimeric complex, and
both free a and bg dimers are capable of modulating activities
of effector enzymes and ion channels (1–3). G protein-mediated
signaling is complicated; a single receptor can activate more
than one kind of heterotrimer, and both the activated a and the
bg subunits can interact with multiple effectors. For example,
the thrombin receptor is known to couple to G12, Gi, and Gq
family members (4), and physiological responses may be the
result of contributions by both a and bg subunits. Furthermore,
cross-talk between these different G protein-regulated path-
ways makes the networks even more complex.
One way to analyze this complex network is to specifically
activate a particular Ga in vivo to discern its function without
interference from other G proteins. As a first step toward this
goal, we used site-specific mutagenesis to switch the nucleotide
specificity of Ga from guanine to xanthine nucleotides. In cells,
xanothine monophosphate is an intermediate in the biosynthe-
sis of GMP; however, the steady-state concentrations of XDP
and XTP are relatively low (5). Thus, by subsequent introduc-
tion of XTP, we should be able to specifically activate the
mutant protein. The a subunits of heterotrimeric G proteins
belong to the GTPase superfamily that also includes factors
involved in ribosomal protein synthesis, such as EF-Tu, and a
large number of Ras-like small guanine nucleotide binding
proteins (6, 7). Crystal structures of the a subunits of transdu-
cin and Gi have been recently solved (8–11). Both Ga struc-
tures had nearly identical binding pockets for the guanine
nucleotide, which was similar to the guanine nucleotide bind-
ing pocket revealed in the crystal structures of Ras (12) and
EF-Tu (13, 14). One of the conserved features was the interac-
tion between a specific Ga amino acid residue and the guanine
nucleotide ring, i.e. a hydrogen bond from the side chain of a
conserved aspartic acid (Asp-268 in transducin) to the N-1
nitrogen and the N2 amine of the guanine ring (see Fig. 1a).
Asp-268 of transducin belongs to a conserved motif (NKXD)
found in the GTPase superfamily. It has been shown that the
characteristic hydrogen bond formed with the aspartic acid
residue determines the specificity of guanine nucleotide bind-
ing in other GTP-binding proteins, such as EF-Tu and Ras (15,
16). A mutation of aspartate to asparagine at this position in
several GTP binding proteins, including EF-Tu (17, 18), Ypt1
(19), rab-5 (20, 21), and FtsY (22) and adenylosuccinate syn-
thetase (23), leads to active proteins regulated by xanthine
nucleotides instead of guanine nucleotides. In this report, we
studied the effect of the similar D273N mutation on nucleotide
binding specificity of Goa.
MATERIALS AND METHODS
Mutagenesis and Expression of the Goa—Myristoylated recombinant
mouse GoAa was expressed in Escherichia coli. Conditions for growth,
induction, and lysis of the Goa-expressing cells were described previ-
ously (24). The D273N mutation was introduced in both wild-type Goa
and the activated mutant GoaQ205L by oligonucleotide-directed mu-
tagenesis. The oligonucleotide TTTCTAAACAAGAAAAATTTATTTG-
GCGAGAAGATTAAGAAGTC was annealed to uracil-containing sin-
gle-stranded DNA from the plasmids pGoa and pGoaQ205L. The
resulting vectors were designated as pGoaD273N and pGoaX.
Expression and Purification of His6-tagged Goa—We subcloned wild
type and mutant Goa cDNAs into the E. coli expression vector pET-15b
(Novagen), which added a peptide of 20 amino acids MGSS(H6)-
SSGLVPRGSH containing the His6 tag and a thrombin site upstream of
the amino terminus of Goa. These clones were used to transform the E.
coli strain BL21(DE3), and proteins were expressed. After harvesting
the culture, cell extracts were resuspended in the binding buffer (5 mM
imidazole, 0.5 M NaCl, 160 mM Tris-HCl, pH 7.9, 1 mM bMe). Binding to
the Ni21-NTA resin was according to the protocol provided by Novagen.
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The His6-tagged protein was eluted with a gradient of imidazole con-
centration (5–500 mM). The Goa and various mutant proteins eluted at
about 250 mM imidazole. Proteins were then transferred to TED buffer
(20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT) with 0.1 mM MgCl2
and 0.1 mM nucleotide diphosphate (GDP or XDP as appropriate) by gel
filtration. Purified proteins were stored in 50% glycerol at 270 °C.
Synthesis of XTPgS—XTPgS was synthesized from XDP and ATPgS
with nucleotide diphosphate kinase (NDK) as described previously (25).
To produce 35S-labeled XTPgS, the reaction contained 10 mM XDP, 1 mM
[35S]ATPgS, and 10 units NDK (Sigma) in 100 ml of NDK buffer (1 mM
MgCl2, 5 mM DTT, 20 mM Tris-HCl, pH 8.0). The mixture was incubated
at room temperature for 2 h. The resulting concentration of [35S]XTPgS
was about 1 mM (1 mCi/pmol). The radiochemical purity of XTPgS was
monitored by thin layer chromatography on Avicel/DEAE plates (Anal-
tech) in 0.07 N HCl.
Nucleotide Binding—Binding of [35S]GTPgS and [35S]XTPgS to the
recombinant Goa and the mutant proteins was performed as described
(24). The binding reaction contained 0.5 mg of purified protein or 200 mg
of crude E. coli protein in TED buffer with 0.1 mM MgCl2, 1 mM ATP, and
0.1 mM GTPgS or XTPgS (20,000 cpm/pmol). For the time course exper-
iments, 20-ml aliquots were withdrawn from a 200-ml reaction, diluted
10-fold with ice-cold TED buffer containing 0.1 mM MgCl2, filtered
through a 0.45-mm nitrocellulose filter, washed, and dried. The amount
of bound radioactivity was determined by scintillation counting.
Proteolysis with Trypsin—Approximately 0.1 mg of purified recombi-
nant Goa was preincubated with nucleotide at room temperature for 30
min in the TED buffer. 10 ng of trypsin was then added to the mixture,
and the reaction was terminated after 10 min by addition of an equal
volume of 2 3 SDS-PAGE sample buffer and heating for 3 min at
100 °C. The proteolytic pattern was subsequently analyzed by Western
blot using antibodies against Goa.
ADP-ribosylation by Pertussis Toxin—Pertussis toxin-catalyzed
ADP-ribosylation was performed as described (24). Briefly, 0.1 mg of
recombinant Goa was mixed with 0.1 mg of purified retinal bg subunit
complex in the presence of the appropriate nucleotide and incubated for
10 min at room temperature before addition of the reaction mixture
(final concentration of 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 2 mM
MgCl2, 2 mM DTT, 0.5 mM [
32P]NAD (20,000 cpm/pmol), and 10 mg/ml
pertussis toxin (List Biologicals)). Reactions were incubated for 30 min
at room temperature and terminated by the addition of 5 3 SDS-PAGE
sample buffer. Samples were resolved on SDS-PAGE. Gels were stained
with Coomassie Blue, dried, and exposed to x-ray film.
Cell Culture and Transfection—COS-7 cells were cultured in Dulbec-
co’s modified Eagle’s medium containing 10% fetal calf serum. 1 3 105
cells/well were seeded in 12-well plates 1 day before transfection. All
transfection assays contained a total amount of 1 mg of DNA; the
plasmid pCIS encoding b-galactosidase was used to maintain a constant
amount of DNA. To each well, 1 mg of DNA was mixed with 5 ml of
lipofectamine (Life Technologies, Inc.) in 0.5 ml of Opti-MEM (Life Tech-
nologies, Inc.), and five h later, 0.5 ml of 20% fetal calf serum in Dulbecco’s
modified Eagle’s medium was added to the cells. After 48 h, cells were
assayed for inositol phosphate levels as described previously (26, 27).
Permeabilization of COS-7 Cell Membranes—Transfected COS-7
cells were washed twice with phosphate-buffered saline and incubated
in 200 ml of permeabilization solution consisting of 115 mM KCl, 15 mM
NaCl, 0.5 mM MgCl2, 20 mM Hepes-NaOH, pH 7, 1 mM EGTA, 100 mM
ATP, 0.37 mM CaCl2 (to give a free Ca
21 concentration of 100 nM), and
200 units/ml a-toxin with or without 0.1 mM XDP for 10 min at 37 °C.
Then 2 ml of 1 M LiCl was added before the inositol phosphate assay.
RESULTS
To change the binding specificity of Goa from guanine nu-
cleotides to xanthine nucleotides, we replaced Asp-273 by an
asparagine residue, which was expected on the basis of struc-
tural analysis to coordinate with xanthine instead of guanine
(Fig. 1b). This mutation was introduced into both the wild-type
Goa subunit and the GTPase-deficient Goa mutant (Q205L).
We chose Goa because myristoylated Goa can be expressed in
E. coli, and it has been shown that many of the characteristics
of the recombinant Goa protein are similar to those of the
protein isolated from brain. To further characterize the func-
tion of XTP-bound Goa mutants, we purified these proteins in
the form of non-myristoylated His6-tagged Goa by affinity chro-
matography on a Ni21-NTA column. It has been shown that the
non-myristoylated form of Goa has identical nucleotide binding
properties compared with the myristoylated form, and it also
forms trimeric complexes with bg subunits although the affin-
ity to bg is much less than the myristoylated form (44).
Binding of GTPgS and XTPgS—The nucleotide binding of
Goa, GoaD273N, and GoaX (GoaD273N/Q205L) was assayed
with [35S]GTPgS and [35S]XTPgS. In E. coli crude extracts,
Goa reached maximum binding of GTPgS in about 30 min (Fig.
2a). As expected, Goa showed no affinity for XTPgS. However,
GoaX revealed a switch in nucleotide specificity. As shown in
Fig. 2b, GoaX had high affinity for XTPgS but not for GTPgS.
Interestingly, only the double mutant was active while
GoaD273N did not bind either GTPgS or XTPgS (data not
shown). Goa binds GTPgS very tightly in the presence of 1 mM
Mg21 (28, 29). Both Goa (Fig. 2c) and GoaX (Fig. 2d) did not
exchange bound [35S]NTPgS when excess non-radioactive nu-
cleotides were subsequently added.
The purified His6-tagged proteins in general retained the
properties of the untagged myristoylated a subunits. However,
we detected some differences in nucleotide binding. His6-
tagged Goa or GoaX bound GTPgS or XTPgS, respectively, but
the binding was less stable than with the untagged myristoy-
lated protein. In the case of His6-tagged Goa, the bound GTPgS
could be exchanged after excess non-radioactive GTPgS was
added (Fig. 2c). Similar behavior was observed in the XTPgS
binding of pure His6-tagged GoaX, which also showed distinct
nucleotide exchange after non-radioactive XDP or XTP were
added to the binding reaction (Fig. 2d). The decrease in nucle-
otide affinity was apparently the result of the presence of the
His6-tag. Although the nucleotide binding of His6-tagged pro-
teins was less stable, the specificity of binding was clearly
maintained, and the mutant bound the xanthine nucleotides
rather than the guanine nucleotides. As expected, the purified
single mutant GoaD273N did not show any nucleotide binding
activity (data not shown).
Activation Conformational Change as Assessed by Limited
Proteolysis—Guanine nucleotides protect G protein a subunits,
including Goa, from complete proteolytic degradation (30–32).
The pattern of fragments derived from partial tryptic digestion
can be used as an indicator of the conformation of the protein.
In the presence of GDP, Goa is hydrolyzed by trypsin resulting
in two products, a stable 25-kDa and an unstable 17-kDa
peptide. Binding of non-hydrolyzable analogs of GTP can in-
duce an active conformation of the Goa subunit, which is re-
sistant to proteolytic degradation, and protects a stable 37-kDa
polypeptide from further degradation. In the case of the acti-
vated mutant GoaQ205L, GTP can also protect the remaining
37-kDa polypeptide from complete proteolytic digestion by
trypsin because GoaQ205L lacks GTPase activity. Fig. 3a
shows that XTP protects GoaX from proteolysis by trypsin
(lanes 4 and 5), whereas in the control experiment, GTPgS
protected wild-type Goa (lane 8). This experiment indicates
that GoaX binds XTP without hydrolyzing it. After binding to
XTP, GoaX must have assumed a conformation similar to that
of GTPgS-bound wild-type Goa. In this experiment, wild-type
FIG. 1. a, interaction between the aspartic acid side chain at position
268 in the a subunit of transducin with the guanine ring of GTPgS,
revealed by the solved crystal structure. b, a proposed model for the
interaction between the substituted asparagine residue at position 273
in Goa and the xanthine ring.
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Goa needed only 1 mM GTPgS to prevent complete proteolysis.
Similarly, GoaX was sufficiently protected in the presence of 1
mM XTP. It is noteworthy that GTPgS, but not GTP, was also
able to protect GoaX from complete tryptic digestion although
this protection required GTPgS concentrations above 100 mM
(lanes 1, 2, and 3). Thus, GoaX has a much lower affinity for
GTPgS than for XTP. We did not detect any of GTPgS binding
activity of GoaX in our nucleotide binding assay because the
highest concentrations of [35S]GTPgS used in the reaction were
micromolar. Consistent with the results of the nucleotide bind-
ing experiments, the single mutant GoaD273N was not pro-
tected by any nucleotides including GTP, GTPgS, and XTP up
to millimolar concentrations (data not shown).
Pertussis Toxin-induced ADP-ribosylation—The interaction
of Goa with the bg complex can be assayed by ADP-ribosylation
of the a subunit induced by pertussis toxin (PTX) because
ADP-ribosylation requires the formation of the heterotrimeric
complex (33, 34). Modification (by ADP-ribosylation) of recom-
binant Goa catalyzed by PTX is the same in the presence of
GTP or GDP because of the GTPase activity of Goa. However,
GTPgS strongly inhibits the modification since Goa cannot
hydrolyze GTPgS. GTPgS binding thus promotes the dissocia-
tion of the trimeric abg complex and prevents the ADP-ribosy-
lation of the Goa subunit. The activated GoaQ205L mutant
lacks GTPase activity, and the effect of GTP on ADP-ribosyla-
tion is similar to that of GTPgS on the wild-type Goa. There-
fore, PTX labeling can be used not only to examine bg binding
but also GTPase activity. Fig. 3b shows that purified Goa was
ADP-ribosylated by pertussis toxin (lane 7), and the labeling
was strongly inhibited by GTPgS (lane 6). In contrast, GoaX
was modified by pertussis toxin only in the presence of XDP
(lane 4) but not with GDP (lane 5), and as expected, the reac-
tion was strongly inhibited by XTP (lane 2), whereas GTP had
no effect (lane 3). Therefore, only XDP-bound GoaX can form
trimeric complexes with bg, and binding of XTP induces disso-
ciation of the trimeric complex. As a control, we did not detect
any ADP-ribosylation of GoaX when GTPgS, GTP, or XTP
alone was present (data not shown). Consistent with the re-
sults of trypsin digestion, this experiment indicated that XTP
was not hydrolyzed by GoaX. The quantitation of [32P]ADP-
ribose incorporation revealed that the labeling of GoaX was
proportional to the amount of bg used and reached a maximum
at a GoaX:bg ratio of 1:1, similar to wild-type Goa (data not
shown). Interestingly, high concentrations (over 100 mM) of
GTPgS also inhibited the ADP-ribosylation of GoaX (Fig. 3b,
lane 1), offering further evidence that GoaX was able to bind
GTPgS with low affinity. As expected, GoaD273N did not in-
teract with bg and was not modified by pertussis toxin in the
presence of either GDP or XDP (data not shown).
XDP-dependent bg Interaction in Transfected COS-7
Cells—In transfected COS-7 cells, b1g2 is able to activate
PLCb2, and the activation of PLCb2 can be inhibited by co-
transfection with Goa because of competition for bg (35). We
cotransfected COS-7 cells with PLCb2, b1, g2, and GoaD273N
or GoaX and found that both Goa mutants did not inhibit
PLCb2 activity, whereas wild-type Goa did. This experiment
indicates that both mutants do not bind bg in COS-7 cells and
is consistent with the in vitro experiments on PTX-induced
ADP-ribosylation. GoaX bound bg only in the presence of XDP,
and because XDP concentration is negligible inside the cell, the
FIG. 2. GoaX binds XTPgS but not
GTPgS. 20 ml of the E. coli extract con-
taining wild-type Goa (a) or GoaX (b) was
diluted 10-fold with TEDM buffer (20 mM
Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT,
1 mM MgCl2) containing either 0.1 mM
[35S]GTPgS or [35S]XTPgS (20,000 cpm/
pmol) and incubated at room tempera-
ture. At the indicated times, 20-ml ali-
quots were withdrawn and assayed for
the bound nucleotides. GTPgS binding of
the purified His6-tagged Goa (c) and
XTPgS binding of the purified His6-
tagged GoaX (d) were compared with
those of untagged Goa and GoaX in the E.
coli extract. After 40 min, 1 mM unlabeled
GTPgS (c) or XTP (d) was introduced into
the reaction.
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interaction did not occur. To deliver XDP into cells, we tried to
permeabilize COS-7 cells by several methods including digito-
nin treatment, electroporation, and a-toxin (36). We found that
only a-toxin gave us consistent results and had no effect on the
PLCb2 activities stimulated by bg. After incubating cells with
a-toxin in the presence of XDP, we found that GoaX inhibited
PLCb2 activity, whereas GoaD273N was not affected by XDP
(Fig. 4). In the control experiments, we found that adding GDP
or GTP to the permeabilization buffer had no effect on the
PLCb2 activity of cells transfected with the Goa mutants (data
not shown). This experiment shows that the Goa mutants
behave similarly in vitro and in cultured cells; GoaX binds bg
only when exogenous XDP is available.
DISCUSSION
We engineered a mutant of Goa that switched nucleotide
binding activity from guanine nucleotides to xanthine nucle-
otides. The mutation (D273N) was at a conserved residue of
the NKXD motif that appears in all GTPase superfamily
proteins. Crystal structures of transducin and Gi showed that
this aspartic acid residue participated in hydrogen bonding to
the guanine ring (Fig. 1a). The proposed interaction between
the mutagenized Asn and the xanthine ring is shown in Fig.
1b in which the hydrogen bond is “flipped” when compared
with wild-type Ga. Similar single Asp3Asn mutations have
been made in other GTP binding proteins, including EF-Tu
(17, 18), Ypt1 (19), rab-5 (20, 21), and FtsY (22), and E. coli
adenylosuccinate synthetase (23), resulting in active proteins
regulated by xanthine nucleotides instead of guanine nucle-
otides. However, the similar D119N mutant of H-Ras induced
transformation of NIH-3T3 cells with efficiency indistin-
guishable from wild-type H-Ras (16, 37). Although the mu-
tant D119N Ras exhibited decreased affinity for GTP and
increased affinity for XTP (by 2 to 3 orders of magnitude), the
high intracellular concentration of GTP (millimolar) probably
ensures that the protein is still bound to the guanine nucle-
otides in the cell. Interestingly, we found the corresponding
D273N mutation in Goa did not result in binding of either
GTPgS or XTPgS, whereas the D273N/Q205L double mutant,
GoaX, switched nucleotide binding ability. When examining
the crystal structure of transducin, it is not clear why the
FIG. 4. The interaction of GoaX with bg in transfected COS-7
cells is XDP-dependent. 1 3 105 cells/well were seeded in a 12-well
plate and then were transfected with cDNAs encoding the indicated
proteins the next day. The total amount of cDNA for each well was
adjusted to 1.0 mg by addition of CMV-LacZ cDNA. Cells were labeled
with [3H]inositol, and the levels of inositol phosphates were determined
after incubating cells with 200 units/ml a-toxin with or without 1024 M
XDP.
FIG. 3. Functional Regulation of Goa by Xanthine Nucleotides. a, XTP protects the proteolysis of GoaX with trypsin. 0.1 mg of purified
recombinant Goa or GoaX was incubated with indicated nucleotides at room temperature for 30 min. 10 ng of trypsin was then added to the
mixture, and the reaction was terminated by addition of an equal volume of 2 3 SDS-PAGE sample buffer. The proteolytic pattern was visualized
by Western blot using an antibody against a C-terminal peptide of Goa. b, PTX-induced ADP-ribosylation of GoaX requires XDP and is inhibited
by XTP. 0.1 mg of purified recombinant Goa or GoaX was mixed with 0.1 mg of purified bovine retinal bg complex in the presence of indicated
nucleotides (100 mM each, including the carry-over GDP or XDP from the protein storage buffer) and incubated for 10 min at room temperature.
Then the reaction mixture containing 10 mg/ml pertussis toxin, 0.5 mM [32P]NAD (20,000 cpm/pmol), and other necessary components were added.
Reactions were incubated for 30 min at room temperature and terminated by the addition of 10 ml of 5 3 SDS-PAGE sample buffer. The samples were
then resolved on a 10% SDS-polyacrylamide gel and visualized by autoradiography. The arrows indicate the positions of molecular mass markers.
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Gln3Leu mutation (position 200 in transducin a), which is
at the opposite side of the nucleotide binding pocket from the
Asp3Asn mutation (position 268 in transducin a), rescued
the xanthine nucleotide binding of GoaD273N. It is interest-
ing to note that GoaX binds GTPgS at concentrations higher
than 100 mM. In our nucleotide binding experiments, we could
not observe this binding because the affinity was weak, re-
quiring concentrations higher than 1 mM [35S]GTPgS, which
was the highest concentration that we could use. The P–S
bond of the g phosphate in GTPgS is longer than the P–O
bond in GTP, which not only prevents nucleotide hydrolysis
when binding to G protein a subunits, it also results in
qualitatively different interactions and different affinities.
In vitro experiments using limited trypsin digestion and
PTX-induced ADP-ribosylation showed that GoaX retained the
characteristic properties of wild-type Goa in the presence of
XDP or XTP. In addition, our data confirm the assumption that
diphosphate nucleotides are required for the interaction of G
protein a subunits with bg subunits. XTP-bound GoaX as-
sumed a trypsin-resistant conformation similar to that of the
activated wild-type Goa and stimulated bg dissociation from
the trimeric complex, suggesting that GoaX can be activated by
XTP. In transfected COS-7 cells, PLCb2 is activated by G
protein bg subunits, and the activity is inhibited when cotrans-
fecting with Goa because of the competition for bg. To study bg
binding of the mutant GoaX in vivo, we looked for inhibition of
PLCb2 activity as an indication of bg binding. We found that
GoaX did not affect bg-stimulated PLCb2 activity because of
the absence of XDP. To turn on bg binding, we used a-toxin to
make cell membranes permeable to XDP, and indeed under
these conditions, GoaX attenuated PLCb2 activity. G protein-
derived bg subunits are shown to be able to bind many proteins
other than Ga, and may be involved in many signal transduc-
tion pathways. We demonstrated that XDP can be delivered
into cells and GoaX may be used as a bg quencher that can
make the cellular bg pool unavailable to other bg effectors. The
ability to turn on and off bg in vivo could be useful to better
understand the physiological function of bg.
Goa is one of the G protein a subunits whose functions are
not well understood although there is some evidence support-
ing a role in the regulation of calcium channels (38–42). Since
bg subunits are also proposed as regulators of calcium channels
(43), it is difficult to differentiate the activities of Goa and bg in
some situations when activated receptors release both Goa and
bg subunits. This is one of the problems that the GoaX mutant
might be used to address. The channel may be activated di-
rectly by adding XTP without releasing free bg in cells that
have been transfected with cDNA expressing the mutant pro-
tein. Cross-talk between the different G protein-mediated sig-
naling pathways has been well demonstrated. Activating GoaX
directly and instantly by XTP would avoid the interference of
other pathways and help us to differentiate individual path-
ways. Introducing this mutation into other G protein a sub-
units may be used to study their functions as well.
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